Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown that this can be painful.

| More on:
The Motley Fool

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt, which would be yet another catastrophe for shareholders. To save itself from that fate, it is currently negotiating with its lenders to ease covenants.

But this has consequences too, as has been demonstrated by a number of oil companies. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) is one example. We’ll take a closer look below.

Valeant’s covenants

According to Valeant’s credit agreement, a default will occur if Valeant doesn’t file its 10-K (which includes audited financial statements) by the end of this month. In that scenario, Valeant will then have 30 days to cure the default by filing its 10-K.

Meanwhile, Valeant has already breached the reporting covenant in its bond indentures, which required a 10-K by March 16. As a result, the company is restricted from borrowing any more money from its revolver.

These aren’t the only covenants Valeant must adhere to; there are also certain financial targets that the company must maintain. The company said it expects to be in compliance with all covenants this year and next, but until the company releases audited financials, it’s impossible to know for sure.

Penn West’s experience

At the beginning of last year Penn West was about to breach its debt covenants, which would have meant a default. To avoid such a fate, the company got lenders to relax covenants. And even though an agreement was reached, it was not a fun process.

For starters, Penn West had to lower its quarterly dividend from $0.03 to $0.01. The company also had to cancel a $500 million tranche in its bank facility. It also had to grant floating charge security over all its property. If that wasn’t bad enough, Penn West had to pledge that any asset sales would go towards reducing debt. To top it all off, the company had to agree to higher interest payments.

Anything can happen

This situation with Valeant is a little different, because Valeant hasn’t even released audited financials, making the outcome very unpredictable. Otherwise, Penn West’s experience provides a useful learning experience.

And anonymous sources have already told Reuters that “creditors prepare to slam company with tougher demands” in exchange for relaxing covenants. So one way or another, Valeant is in for a rough ride. This story is far from over.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

dividends can compound over time
Dividend Stocks

2 High-Yield Dividend Stocks That Could Be a Safer Pick for Canadian Retirees

These high-yield dividend stocks are backed by businesses that generate steady cash flow and maintain sustainable payout ratios.

Read more »

House models and one with REIT real estate investment trust.
Dividend Stocks

My 2 Favourite Stocks for Monthly Passive Income

These monthly income-focused Canadian stocks could help investors build a stronger passive-income stream.

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

Investors: Why Many Canadians Aren’t Using Their TFSA the Right Way

Add this dividend-focused Canadian ETF to your TFSA to make the most of the valuable contribution room in your tax-sheltered…

Read more »

Senior uses a laptop computer
Dividend Stocks

Use a TFSA to Make $500 in Monthly Tax-Free Income

Backed by resilient business models, dependable cash flows, and solid long-term growth prospects, these two dividend stocks can generate more…

Read more »

people stand in a line to wait at an airport
Dividend Stocks

Here’s the Average TFSA and RRSP at Age 45

Here’s a stock you can add to your self-directed investment portfolio to cover the gap between your TFSA and RRSP…

Read more »

dividends grow over time
Dividend Stocks

This TSX Dividend Yield Looks Almost Too Good: Here’s What the Numbers Actually Show

This TSX dividend stock's double-digit yield looks credible once you dig into the numbers.

Read more »

middle-aged couple work together on laptop
Energy Stocks

The Average TFSA Balance at 55, and How to Improve Yours

Canadians in their mid-50s can improve their financial standing within 10 years by using their unused TFSA contribution room.

Read more »

monthly desk calendar
Dividend Stocks

2 Monthly Dividend Stocks I’d Buy for Steady Cash Flow

Two dividend stocks are ‘strong buy’ options for investors seeking steady cash flow every month.

Read more »